BIO.NRW COVID-19 Information and Contact Platform
At this point BIO.NRW offers all companies and scientists in NRW a platform with actual informations in connection with the COVID-19 pandemic. This includes support programs and funding from the state, the federal government and the EU as well as relevant news from companies and science.
In addition, we also offer you the possibility of individual cooperation and contact requests: If you have offers for your (product) development regarding COVID-19 in the fields of diagnostics, therapy, prevention, clinical studies or in a broader sense to medical technology solutions and/or are looking for partners, please feel free to contact us via email at bio.nrw@bio.nrw.de.
We will publish your offers and/or requests in this area. In case you do not wish to publish your information, you are nevertheless welcome to contact the office so that we can support you while maintaining confidentiality.
Click here for the contact form.
Corona platform of the EU with information on funding opportunities related with Covid-19
Weiterlesen …
Overview of COVID-19 associated (and general) funding, financing, information
Weiterlesen …
COVID-19 News
Fast SARS-CoV-2 RNA extraction for high-throughput
Fast SARS-CoV-2 RNA extraction for high-throughput BioEcho developed a rapid extraction protocol that reduces the isolation of SARS-CoV-2-RNA to just a few m...
antibodies-online SARS-CoV-2 Handbook
antibodies-online SARS-CoV-2 Handbook In order to overcome the ongoing COVID-19 pandemic, it is essential to understand the underlying biology of SARS-CoV-2,...
Coronavirus: Commission mobilises €123 million for research and innovation to combat the threat of variants
Coronavirus: Commission mobilises €123 million for research and innovation to combat the threat of variants The Commission is mobilising €123 million fro...
Vaccines: Commission hosts first EU matchmaking event to mobilise Europe’s full potentialfor the production of COVID-19 vaccines
Vaccines: Commission hosts first EU matchmaking event to mobilise Europe’s full potentialfor the production of COVID-19 vaccines Today, the Commission ...
Covid-19: EMA recommends conditional approval for Janssen vaccine
Covid-19: EMA recommends conditional approval for Janssen vaccine The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency ...
European Commission authorises fourth vaccine against COVID-19
European Commission authorises fourth vaccine against COVID-19 Press release March 11 Today, the European Commission has granted a conditional marketing auth...
Cologne’s university medicine to coordinate EU vaccine research network VACCELERATE
Cologne’s university medicine to coordinate EU vaccine research network VACCELERATE New consortium of research institutions will coordinate vaccine trials ...
EU-Commission establishs HERA Incubator
EU-Commission establishs HERA Incubator EU-Commission has proposed an European bio-defence preparedness plan against COVID-19 variants, the so called “HERA...
Evonik strengthens strategic partnership with BioNTech on COVID-19 vaccine
Evonik strengthens strategic partnership with BioNTech on COVID-19 vaccine Establishment of additional lipid production in Germany for use with mRNA-based va...
Positive interim phase 1/2a data on Janssen’s COVID19 vaccine candidate.
The New England Journal of Medicine (NEJM) has published interim phase 1/2a data for Janssen’s Covid19 vaccine candidate. They show that the vaccine ca...
DiosCURE to Develop Highly Specific Single-Chain Antibodies Against SARS-CoV-2
DiosCURE to Develop Highly Specific Single-Chain Antibodies Against SARS-CoV-2 Core technology includes promising bivalent single-domain antibodies simultane...
CureVac and Bayer join forces on COVID-19 vaccine candidate CVnCoV
Bayer to support CureVac in numerous areas, including development and supply of CVnCoV, they plan to facilitate the supply of several hundred million doses.<...
Phase II Clinical Trial of the COVID-19 Vaccine of Janssen Authorised in Germany
Phase II Clinical Trial of the COVID-19 Vaccine of Janssen Authorised in Germany The Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines, ...
QIAGEN to launch rapid portable test that can detect active infections of SARS-CoV-2 in less than 15 min
Access Anti-SARS-CoV-2 Antigen Test, developed in collaboration with Ellume, is easy to use and provides accurate results in less than 15 minutes…
...Events
BIO.NRW Breakfast Club – für alle Gründer, Gründungsinteressierten und Start-ups
Weiterlesen …
Innovations for a New Textile Industry
Weiterlesen …
BIO.NRW.eco ist dabei: Die Greener Manufacturing Show 2021 in Köln
Weiterlesen …
Künstliche Intelligenz in der roten Biotechnologie
Weiterlesen …
BIO.NRW – Symposium: Zukünftige Pandemien – was konnten Wirtschaft und Gesellschaft durch COVID-19 lernen?
Weiterlesen …
„Das Mikrobiom als individuelle Signatur des Menschen und seine klinische Relevanz“
Weiterlesen …
BIO-EUROPE Spring 2021
Weiterlesen …
Our Databases
Database of Biotech Companies
in North-Rhine Westphalia
BIO.NRW offers you a free of charge, well-structured and comprehensive database of Life science and biotechnology companies in North-Rhine Westphalia. The information includes company profiles with contact details, a summary of products, services, and technologies.
Academic Database
in North-Rhine Westphalia
This database is the first of its kind in Germany and aims to facilitate the cooperation between science and industry. The database is updated constantly.
Media
publications and presentations
BIO.NRW offers you information about the science and business location of North-Rhine Westphalia. Besides you can find information about financing, subsidies and other exciting topics of the biotechnology and bioeconomy field.
Contact
Address
Geschäftsstelle BIO.NRW
Merowingerplatz 1
D-40225 Düsseldorf
Please feel free to contact us
Data Protection Notice
You can revoke the personal data collected and processed by you within the scope of this form for the purpose of fulfilling your request at any time. The legality of the processing based on your consent remains unaffected until receipt of your revocation. You can find more detailed information in our privacy policy.
Mit dem Laden der Karte akzeptieren Sie die Datenschutzerklärung von Google.
Mehr erfahren
